Low-molecular-weight heparin compared with unfractionated heparin for patients with non–ST-segment elevation acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors: Results from the CRUSADE initiative

By Singh Kanwar   Roe Matthew   Peterson Eric   Chen Anita   Mahaffey Kenneth   Goodman Shaun   Harrington Robert   Smith Sidney   Gibler W.   Ohman E.   Pollack Charles  

Journal of Thrombosis and Thrombolysis, Vol. 21, Iss. 3, 2006-06 ,pp. : 211-220

Springer Publishing Company

Access to resources Recommend Favorite

Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the national registry of myocardial infarction 4

By Peterson E.D.   Pollack C.V.   Roe M.T.   for the National Registry of Myocardial Infarction NRMI 4 Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT

By Akkerhuis K.M.  

European Heart Journal, Vol. 21, Iss. 5, 2000-03 ,pp. : 371-381

Oxford University Press

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Inhibitors in Acute ST-Elevation Myocardial Infarction: Will the Combination with Thrombolytics Become Reality?

By Zeymer Uwe  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 91-97

Springer Publishing Company

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa Receptor Antagonists in the Treatment of Acute ST Elevation MI: From Hypotheses to Unexpected Recent Observations

By Ross Allan M.  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 2, 2003-04 ,pp. : 85-89

Springer Publishing Company

Access to resources Recommend Favorite